Inflammatory bowel disease (IBD) has emerged as a global disease, yet identifying those at higher risk of developing IBD remains challenging. A new study highlights the use of a multi-ethnic polygenic risk score to determine risk of inflammatory bowel disease in a large primary care population.
This is a preview of subscription content, log in via an institution to check access.
References
Hugot, J. P., Chamaillard, M. & Zouali, H. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411, 599–603 (2001).
Liu, J. Z., van Sommeren, S. & Huang, H. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979–986 (2015).
Huang, H., Fang, M. & Jostins, L. et al. Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature 547, 173–178 (2017).
Beaudoin, M., Goyette, P. & Boucher, G. et al. Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS Genet. 9, e1003723 (2013).
Rivas, M. A., Graham, D. & Sulem, P. et al. A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis. Nat. Commun. 7, 12342 (2016).
Brant, S. R., Okou, D. T. & Simpson, C. L. et al. Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. Gastroenterology 152, 206–217 e2 (2017).
Gettler, K. et al. Common and rare variant prediction and penetrance of IBD in a large, multi-ethnic, health system-based biobank cohort. Gastroenterology https://doi.org/10.1053/j.gastro.2020.12.034 (2020).
Tai, Y., Wang, Q. & Korner, H. et al. Molecular Mechanisms of T Cells Activation by Dendritic Cells in Autoimmune Diseases. Front. Pharmacol. 9, 642 (2018).
Torres, J., Hu, J. & Seki, A. et al. Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice. Gut 69, 42–51 (2020).
Torres, J., Petralia, F. & Sato, T. et al. Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis. Gastroenterology 159, 96–104 (2020).
Acknowledgements
A.N.A. is supported by grants from the National Institutes of Health, Crohn’s and Colitis foundation, and the Chleck Family Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.N.A. has served on the scientific advisory board of Kyn Therapeutics, Sun Pharma and Gilead.
Rights and permissions
About this article
Cite this article
Ananthakrishnan, A.N. IBD risk prediction using multi-ethnic polygenic risk scores. Nat Rev Gastroenterol Hepatol 18, 217–218 (2021). https://doi.org/10.1038/s41575-021-00425-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-021-00425-5
- Springer Nature Limited